Korean Journal of Head & Neck Oncology (대한두경부종양학회지)

The Korean Society for Head and Neck Oncology (대한두경부종양학회)
권호 표지

A Case of Metastatic Eccrine Porocarcinoma with a Review of the Literatures

전이성 에크린 한공암종 1예 및 문헌고찰

  • Lee, Jung-Hwan (Department of Internal Medicine, Inha University School of Medicine) ;
  • Lim, Joo-Han (Department of Internal Medicine, Inha University School of Medicine) ;
  • Kim, Lucia (Department of Pathology, Inha University School of Medicine) ;
  • Kim, Chu-Soo (Department of Internal Medicine, Inha University School of Medicine) ;
  • Yi, Hyeon-Gyu (Department of Internal Medicine, Inha University School of Medicine) ;
  • Nah, So-Yun (Department of Internal Medicine, Inha University School of Medicine) ;
  • Kim, Seong-Hyun (Department of Internal Medicine, Inha University School of Medicine) ;
  • Jeong, Ji-Joong (Department of Internal Medicine, Inha University School of Medicine) ;
  • Lee, Myung-Dong (Department of Internal Medicine, Inha University School of Medicine) ;
  • Ye, Jea-Ho (Department of Internal Medicine, Inha University School of Medicine) ;
  • Lee, Moon-Hee (Department of Internal Medicine, Inha University School of Medicine)
  • 이정환 (인하대학교 의학전문대학원 내과학교실) ;
  • 임주한 (인하대학교 의학전문대학원 내과학교실) ;
  • 김루시아 (인하대학교 의학전문대학원 병리학교실) ;
  • 김철수 (인하대학교 의학전문대학원 내과학교실) ;
  • 이현규 (인하대학교 의학전문대학원 내과학교실) ;
  • 나소연 (인하대학교 의학전문대학원 내과학교실) ;
  • 김성현 (인하대학교 의학전문대학원 내과학교실) ;
  • 정지중 (인하대학교 의학전문대학원 내과학교실) ;
  • 이명동 (인하대학교 의학전문대학원 내과학교실) ;
  • 예재호 (인하대학교 의학전문대학원 내과학교실) ;
  • 이문희 (인하대학교 의학전문대학원 내과학교실)
  • Received : 2011.08.23
  • Accepted : 2011.10.11
  • Published : 2011.11.25
Download PDF
⟨ Previous Next ⟩

Abstract

에크린 한공암종은 흔하지 않으며, 전이성 에크린 한공암종은 매우 드문 암이다. 에크린 한공암종은 표피내 한관에서 기원하는 피부 부속기 악성 종양으로, 대부분 에크린 한공암종은 항암치료와 방사선치료에 효과가 없으며, 따라서 유일한 치료방법은 전이되기 전에 국소 및 광범위 절제술을 시행하여야 한다. 본 환자는 두피에 발생한 에크린 한공암종이 점점 진행하여 피부, 림프절, 폐 등으로 전이하였고, 다수의 광범위 절제술에 이어 항암치료와 방사선치료를 받았지만, 결국 폐전이가 악화되어 사망하였다. 본 저자들은 항암치료와 방사선치료에 불응한 에크린 한공암종 1예를 치료에 대한 문헌고찰과 더불어 보고하는 바이다.

Keywords

References

  1. Pinkus H, Mehregan AH. Epidermotropic Eccrine Carcinoma. A Case Combining Features of Eccrine Poroma and Paget's Dermatosis. Arch Dermatol. 1963;88:597-606. https://doi.org/10.1001/archderm.1963.01590230105015
  2. Kim JW, Oh DJ, Kang MS, Lee D, Hwang SW, Park SW. A case of metastatic eccrine porocarcinoma. Acta Derm Venerel. 2007; 87:550-552. https://doi.org/10.2340/00015555-0310
  3. Girishkumar H, Kamineni S, Hwang RR, Levy J, Sadler R. Eccrine porocarcinoma. Dermatol Surg. 1997;23:583-584. https://doi.org/10.1016/S1076-0512(97)00135-0
  4. Robson A, Greene J, Ansari N, Kim B, Seed PT, McKee PH, et al. Eccrine porocarcinoma(malignant eccrine poroma): A clinicopathologic study of 69 cases. Am J Surg Pathol. 2001;25:710- 720. https://doi.org/10.1097/00000478-200106000-00002
  5. Huet P, Dandurand M, Pignodel C, Guillot B. Metastasizing eccrine porocarcinoma: Report of a case and review of the literature. J Am Acad Dermatol. 1996;35:860-864. https://doi.org/10.1016/S0190-9622(96)90105-X
  6. Ishikawa K. Malignant hidroacanthoma simplex. Arch Dermatol. 1971;104:529-532. https://doi.org/10.1001/archderm.1971.04000230071012
  7. Shiohara J, Koga H, Uhara H, Takata M, Saida T. Eccrine porocarcinoma: Clinical and pathological studies of 12 cases. J Dermatol. 2007;34:516-522. https://doi.org/10.1111/j.1346-8138.2007.00324.x
  8. Grimme H, Petres A, Bergen E, Wiemers S, Schopf E, Vanscheidt W. Metastasizing porocarcinoma of the head with lethal outcome. Dermatology. 1999;198:298-300. https://doi.org/10.1159/000018135
  9. Nouri K, Rivas MP, Pedroso F, Bhatia R, Civantos F. Sentinel lymph node biopsy for high-risk cutaneous squamous cell carcinomas of the head and neck. Arch Dermatol. 2004;140:1284. https://doi.org/10.1001/archderm.140.10.1284-b
  10. Vaz Salgado MA, Garcia CG, Lopez Martin JA, Guerra E, Benito A, Sepulveda JM, et al. Porocarcinoma: Clinical evolution. Dermatol Surg. 2010;36(2):264-267. https://doi.org/10.1111/j.1524-4725.2009.01412.x
  11. Pernia LR, Guzman-Stein G, Miller HL. Surgical treatment of an aggressive metastasized eccrine poroma. Ann Plast Surg. 1993;30:257-259. https://doi.org/10.1097/00000637-199303000-00010
  12. Plunkett TA, Hanby AM, Miles DW, Rubens RD. Metastatic eccrine porocarcinoma: Response to docetaxel(Taxotere) chemotherapy. Ann Oncol. 2001;12:411-414. https://doi.org/10.1023/A:1011196615177
  13. Piedbois P, Breau JL, Morere JF, Israel L. Sweat gland carcinoma with bone and visceral metastasis: Prolonged complete remission lasting 16 months as a result of chemotherapy. Cancer. 1987;60:170-172. https://doi.org/10.1002/1097-0142(19870715)60:2<170::AID-CNCR2820600208>3.0.CO;2-R
  14. Gonzalez-Lopez MA, Vazquez-Lopez F, Soler T, Gomez-Diez S, Garcia YH, Manjon JA, et al. Metastatic eccrine porocarcinoma: A 5.6-year follow-up study of a patient treated with a combined therapeutic protocol. Dermatol Surg. 2003;29:1227-1232. https://doi.org/10.1111/j.1524-4725.2003.29393.x
  15. Gutermuth J, Audring H, Voit C, Trefzer U, Haas N. Antitumour activity of paclitaxel and interferon-alpha in a case of metastatic eccrine porocarcinoma. J Eur Acad Dermatol Venereol. 2004;18:477-479. https://doi.org/10.1111/j.1468-3083.2004.00949.x
  16. Tlemcani K, Levine D, Smith RV, Brandwein-Gensler M, Staffenberg DA, Garg MK, et al. Metastatic apocrine carcinoma of the scalp: prolonged response to systemic chemotherapy. J Clin Oncol. 2010;28:e412-e414. https://doi.org/10.1200/JCO.2009.26.1891
  17. Yamashita H, Kadono T, Tamaki K, Nakagawa K. Interesting response to concurrent chemoradiation in metastatic eccrine porocarcinoma. J Dermatol. 2008;35:606-607. https://doi.org/10.1111/j.1346-8138.2008.00533.x